https://www.pharmatell.com/eyes-on-pharma-blogRSS for NodeMon, 11 May 2026 12:41:29 GMThttps://www.pharmatell.com/eyes-on-pharma/pharma-phriday-may-8-202669fc870ff4b0389e41d4edafFri, 08 May 2026 12:00:09 GMTDuncan Emertonhttps://www.pharmatell.com/eyes-on-pharma/eyeson-competitive-strategy69efc1007475e016cb91d668Mon, 04 May 2026 14:34:29 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/pharma-phriday-may-1-202669f37bdbc99eb1cb510b493eFri, 01 May 2026 12:00:19 GMTDuncan Emertonhttps://www.pharmatell.com/eyes-on-pharma/launch-momentum-meets-market-reality-managing-the-levers-for-success69de8a2d934ce577916bf415Thu, 30 Apr 2026 15:33:10 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/building-the-next-wave-pharma-bets-on-new-platforms-delivery-new-targets69de895ec87c857db1f73845Mon, 27 Apr 2026 17:44:59 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/pharma-phriday-april-24-202669e9fcfcd06bed7d1aa096c3Fri, 24 Apr 2026 12:00:14 GMTDuncan Emertonhttps://www.pharmatell.com/eyes-on-pharma/operational-pressure-builds-layoffs-supply-risk-and-regulatory-friction69de8a9266c8cbf1f4c1eafaMon, 20 Apr 2026 12:47:07 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/pharma-phriday-april-17-202669e0ba87b088eb30d613167aFri, 17 Apr 2026 12:00:15 GMTDuncan Emertonhttps://www.pharmatell.com/eyes-on-pharma/pharma-phriday-april-10-202669d7af42c55f668b530720f0Fri, 10 Apr 2026 12:00:36 GMTDuncan Emertonhttps://www.pharmatell.com/eyes-on-pharma/new-entrants-in-alzheimer-s-korsana-raises-175m-to-target-the-blood-brain-barrier69b46a2a96363eb43d374d74Sun, 05 Apr 2026 15:04:48 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/pharma-phriday-april-3-202669cd31ac011a766e716ad267Fri, 03 Apr 2026 12:00:12 GMTDuncan Emertonhttps://www.pharmatell.com/eyes-on-pharma/pharma-phriday-march-27-202669c6a124d38163c9a040ca9dFri, 27 Mar 2026 15:54:15 GMTDuncan Emertonhttps://www.pharmatell.com/eyes-on-pharma/clinical-trial-wins-new-data-in-ophthalmology-for-wamd69b469d4d7b18f7389d238cdMon, 23 Mar 2026 16:45:30 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/eyes-on-regulatory-momentum-fda-decisions-shape-oncology-and-vaccine-markets69b469846f1601b218245703Thu, 19 Mar 2026 15:24:35 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/eyes-on-astrazeneca699b3062b89ac23fa77d3b01Fri, 13 Mar 2026 16:06:32 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/eyes-on-alnylam699b2fc733aebccb4869cc96Sun, 08 Mar 2026 17:52:57 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/eyes-on-bridgebio699b30044494a30051f843a6Tue, 03 Mar 2026 18:18:34 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/eyes-on-moderna699b302d33aebccb4869cd78Mon, 23 Feb 2026 16:32:45 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/buying-the-future-how-pharma-is-using-m-a-to-reset-pipelines6983b37ea5b6c1a5c987abfdThu, 05 Feb 2026 19:22:23 GMTPharmaTellhttps://www.pharmatell.com/eyes-on-pharma/eyes-on-the-evolving-pharma-landscape-part-46951914d82b426413643efeaMon, 26 Jan 2026 06:00:00 GMTPharmaTell